• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DIH Announces Fiscal 2024 Fourth Quarter and Fiscal Year End Financial Results

    7/15/24 5:48:36 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email

    NORWELL, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2024 fourth quarter and year ended March 31, 2024.

    Recent Highlights

    • Revenue of $64.5 million for the fiscal year ended March 31, 2024, representing growth of 19% over the prior year
    • Device revenue of $51.1 million and service revenue of $11.1 million for the fiscal year ended March 31, 2024, representing growth of 18% and 20%, respectively over the prior year
    • Positive operating cash flow of $5.2 million for the year ended March 31, 2024
    • Announced strategic partnership with B. Temia to enrich DIH's rehabilitative solutions through exclusive licensing of B. Temia's Keego™ Dermoskeleton product in North America

    "We are proud of our team and their excellent work over the past year," said Jason Chen, Chairman and CEO of DIH. "Fiscal 2024 was a critical inflection year for DIH and I am encouraged by our performance. We were able to deliver significant commercial growth while simultaneously completing our initial public offering. Additionally, generating positive operating cash flow while furthering operational accomplishments creates a strong foundation for our growth strategy. With our continued industry leadership, we remain committed in our mission to build an integrated platform and consolidate the fragmented rehabilitation industry. We believe consolidation of the industry will accelerate our growth in the coming years and look forward to what fiscal 2025 will bring."

    Financial Results for the Fiscal Year Ended March 31, 2024

    Revenue for the fiscal year ended March 31, 2024, was $64.5 million, an increase of $10.4 million or 19.3% compared to the prior year period. The overall increase was primarily due to an increase in devices sold of $7.7 million, or 17.7%. The increase in devices revenue was driven by higher sales volume in Europe, the Americas and Asia. Services revenue represented an increase of $1.8 million, up 19.5% compared to the prior fiscal year. Other revenues represented an increase of $0.9 million, up 70.6% compared to the prior period.

    Changes in foreign currency exchange rates had a favorable impact on our net sales for the year ended March 31, 2024, resulting in an increase of approximately $1.7 million. This was mainly driven by fluctuations in Euro valuations throughout the period. 

    Gross profit for the fiscal year ended March 31, 2024, was $29.8 million, a decrease of 2.7% compared to the prior period. The decrease was driven by inflationary cost increases on direct costs of goods of approximately $2.2 million. The additional increase in cost of sales is mainly driven by an increase of $0.6 million in an inventory reserve for slow-moving parts and increased overhead and services parts costs of $3.9 million. The impact due to foreign currency translation losses resulted in an increase of approximately $0.1 million.

    Selling, general and administrative expense for the fiscal year ended March 31, 2024, was $25.8 million, an increase of 12.3% compared to the prior period. The increase was primarily due to increase in professional service costs of $1.5 million related to audit, legal and other professional services in preparation for the business combination and becoming a publicly listed company, and investment in finance capacity in preparation for public company reporting obligations. The increase was also attributable to personnel related expenses primarily due to a $1 million increase in pension expense resulting from changes in market yields. The increase was partially offset by a decrease in credit loss provisions. 

    Research and development costs for the fiscal year ended March 31, 2024, were $6.6 million, a decrease of 4% compared to the prior period. The decrease was primarily due to a decrease in the research and development material purchase and external consulting of $0.2 million and charges pertaining to the Gorbel acquisition of $0.4 million, as we focus more on software developments. The decrease was offset by an increase in personnel expenses of $0.3 million.

    Cash and cash equivalents at March 31, 2024 totaled $3.2 million.

    Financial Results for the Fourth Quarter Ended March 31, 2024

    Revenue for the three months ended March 31, 2024 was $19.4 million, a decrease of 10.2% compared to the prior year period. The decrease was due primarily to alignment with customer schedules for order fulfillment, which resulted in a $2.9 million decrease in device revenue. The Company expects to recognize the revenues related to these products in fiscal year 2025.

    Changes in foreign currency exchange rates had a minor favorable impact on our net sales in the three months ended March 31, 2024, resulting in an increase of approximately $0.1 million. This was driven by stabilization of Euro valuations.

    Gross profit for the three months ended March 31, 2024 was $9.8 million, a 33.8% decrease compared to the prior period. The decrease was primarily due to the timing of revenue recognition related to customer-driven installation delays, inflationary cost increases on direct costs of goods, and increased overhead and services parts costs.

    Selling, general and administrative expense for the three months ended March 31, 2024, was $8.1 million, an increase of 19.2% compared to the prior period. The increase was primarily due to increased overhead expense of $1.5 million primarily related to additional IT consultancy expenses and software license costs, as well as an increase in insurance expenses pertaining to the close of the business combination. The increase was offset by a decrease of professional service cost during the three months ended March 31, 2024, related to audit, legal and professional service.

    Research and development costs for the three months ended March 31, 2024, were $1.9 million, a decrease of 2.5% compared to the prior period. The prior period had included charges pertaining to the Gorbel acquisition of $0.1 million with no similar expense in the three months ended March 31, 2023.

    Subsequent Events

    On June 6, 2024, the Company entered into a Securities Purchase Agreement, pursuant to which the Company issued $3.3 million in principal amount of 8% Original Issue Discount Senior Secured Convertible Debentures (the "Debentures"). The Debentures were issued with an original issue discount of $300 thousand, resulting in gross proceeds of approximately $3 million and net proceeds of approximately $2.5 million after deducting estimated offering expenses.

    The Debentures are convertible into an aggregate of 660,000 shares of the Company's Class A Common Stock at a conversion price of $5.00 per share, subject to adjustment. The Debentures mature on December 7, 2025, and bear interest at a rate of 8% per annum, payable monthly beginning one year from the issuance date.

    Provided that no event of default has occurred or is continuing, and at least 33% of the principal amount of the Debentures has either previously been repaid or converted in accordance with the terms of the Debenture, the Company may elect, by notice to the holder of the Debentures, to extend the Maturity Date by six months upon the payment of six months' interest on the then-outstanding principal amount.

    The Debentures are secured by substantially all of the assets of the Company and its domestic subsidiaries, excluding certain specified assets. Additionally, the Company's domestic subsidiaries have provided an unconditional guarantee of the Debentures. In connection with the issuance of the Debentures, the Company also issued warrants to purchase an aggregate of 330,000 shares of Class A Common Stock at an exercise price of $5.00 per share, with a five-year term. 

    Fiscal Year 2025 Outlook

    The Company expects gross revenue for fiscal year 2025 to range between $74 million and $77 million, representing approximately 15%-20% growth over fiscal year 2024.

    About DIH Holding US, Inc.

    DIH stands for the vision to "Deliver Inspiration & Health" to improve the daily lives of millions of people with disabilities and functional impairments through providing devices and solutions enabling intensive rehabilitation. DIH is a global provider of advanced robotic devices that incorporate virtual reality technologies ("VR") to enable research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Built through the mergers of global-leading niche technology providers, DIH is positioning itself as a transformative rehabilitation solutions provider and consolidator of a largely fragmented and manual-labor-driven industry.

    Caution Regarding Forward-Looking Statements

    This press release contains certain statements which are not historical facts, which are forward-looking statements within the meaning of the federal securities laws, for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. These forward-looking statements include certain statements made with respect to the business combination, the services offered by DIH and the markets in which it operates, and DIH's projected future results. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions provided for illustrative purposes only, and projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. These risks and uncertainties include, but are not limited to: general economic, political and business conditions; the ability of DIH to achieve its projected revenue, the failure of DIH realize the anticipated benefits of the recently-completed business combination and access to sources of additional debt or equity capital if needed. While DIH may elect to update these forward-looking statements at some point in the future, DIH specifically disclaims any obligation to do so.

    Investor Contact

    Greg Chodaczek

    332-895-3230

    [email protected]



    DIH HOLDING US, INC.

    CONSOLIDATED BALANCE SHEETS

    (in thousands, except share and per share data, unaudited)
     
      March 31, 
      2024  2023 
    Assets      
    Current assets:      
    Cash and cash equivalents $3,225  $3,175 
    Accounts receivable, net of allowances of $667 and $1,683, respectively  5,197   5,998 
    Inventories, net  7,830   4,850 
    Due from related party  5,688   6,383 
    Other current assets  5,116   4,855 
    Total current assets  27,056   25,261 
    Property, and equipment, net  530   742 
    Capitalized software, net  2,131   2,019 
    Other intangible assets, net  380   380 
    Operating lease, right-of-use assets, net  4,466   2,604 
    Other tax assets  267   1 
    Other assets  905   772 
    Total assets $35,735  $31,779 
    Liabilities and Deficit      
    Current liabilities:      
    Accounts payable $4,305  $2,190 
    Employee compensation  2,664   3,163 
    Due to related party  10,192   6,841 
    Current portion of deferred revenue  5,211   7,714 
    Manufacturing warranty obligation  513   973 
    Current portion of long-term operating lease  1,572   1,005 
    Advance payments from customers  10,562   6,255 
    Accrued expenses and other current liabilities  9,935   8,631 
    Total current liabilities  44,954   36,772 
    Notes payable - related party  11,457   17,301 
    Non-current deferred revenues  4,670   2,282 
    Long-term operating lease  2,917   1,621 
    Deferred tax liabilities  112   110 
    Other non-current liabilities  4,171   2,647 
    Total liabilities $68,281  $60,733 
    Commitments and contingencies      
    Deficit:      
    Preferred Stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at March 31, 2024; no shares authorized, issued and outstanding at March 31, 2023  —   — 
    Common stock, $0.0001 par value; 100,000,000 shares authorized; 34,544,935 shares issued and outstanding at March 31, 2024; 25,000,000 shares authorized, issued and outstanding at March 31, 2023  3   2 
    Additional paid-in-capital  2,613   (1,898)
    Accumulated deficit  (35,212)  (26,769)
    Accumulated other comprehensive income (loss)  50   (289)
    Total deficit $(32,546) $(28,954)
    Total liabilities and deficit $35,735  $31,779 



    DIH HOLDING US, INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

     (in thousands, except per share data, unaudited)
     
     Three Months Ended March 31,  Years Ended March 31, 
      2024  2023  2024  2023 
    Revenue $19,356  $21,556  $64,473  $54,059 
    Cost of sales  9,547   6,742   34,702   23,474 
    Gross profit  9,809   14,814   29,771   30,585 
    Operating expenses:            
    Selling, general, and administrative expense  8,124   6,813   25,776   22,957 
    Research and development  1,928   1,977   6,609   6,919 
    Total operating expenses  10,052   8,790   32,385   29,876 
    Operating income (loss)  (243)  6,024   (2,614)  709 
    Other income (expense):            
    Interest (expense)  (232)  (117)  (693)  (277)
    Other income (expense), net  (3,709)  27   (3,890)  572 
    Total other income (expense)  (3,941)  (90)  (4,583)  295 
    Income (loss) before income taxes  (4,184)  5,934   (7,197)  1,004 
    Income tax expense (benefit)  587   1,255   1,246   2,018 
    Net Income (loss) $(4,771) $4,679  $(8,443) $(1,014)
                 
    Net earnings (loss) per share, basic and diluted $(0.16) $0.19  $(0.32) $(0.04)
    Weighted-average shares outstanding, basic and diluted  30,559   25,000   26,382   25,000 



    DIH HOLDING US, INC.

    CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

    (in thousands, unaudited)
     
      Three Months Ended March 31,  Years Ended March 31, 
      2024  2023  2024  2023 
    Net income (loss) $(4,771) $4,679  $(8,443) $(1,014)
    Other comprehensive (loss) income, net of tax            
    Foreign currency translation adjustments, net of tax of $0  627   (282)  1,455   (503)
    Pension liability adjustments, net of tax of $0  (100)  (230)  (1,116)  (421)
    Other comprehensive (loss) income  (924)  (512)  339   (924)
    Comprehensive loss $(1,938) $4,167  $(8,104) $(1,938)



    DIH HOLDING US, INC. AND SUBSIDIARIES

    INTERIM CONDENSED COMBINED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

    (in thousands, unaudited)
     
     Common Stock         
     Shares(1) Amount Additional

    Paid-In

    Capital
     Accumulated

    Deficit
     Accumulated

    Other Comprehensive

    Income (Loss)
     Total

    Equity

    (Deficit)
     
    Balance, March 31, 2022 25,000,000 $2 $(1,776)$(25,755)$635 $(26,894)
    Net loss —  —  —  (1,014) —  (1,014)
    Other comprehensive loss, net of tax —  —  —  —  (924) (924)
    Net transactions with DIH Cayman —  —  (122) —  —  (122)
    Balance, March 31, 2023 25,000,000 $2 $(1,898)$(26,769)$(289)$(28,954)
                 
    Net loss —  —  —  (8,443) —  (8,443)
    Issuance of common stock upon reverse recapitalization 9,544,935  1  4,511  —  —  4,512 
    Other comprehensive income, net of tax —  —  —  —  339  339 
    Balance, March 31, 2024 34,544,935 $3 $2,613 $(35,212)$50 $(32,546)



    DIH HOLDING US, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands, unaudited)
     
      Years Ended March 31, 
      2024  2023 
    Cash flows from operating activities:      
    Net loss $(8,443) $(1,014)
    Adjustments to reconcile net loss to net cash provided by operating activities:      
    Depreciation and amortization  302   66 
    Provision for credit losses  (1,016)  669 
    Allowance for inventory obsolescence  617   (1,639)
    Noncash business combination expense  3,514   - 
    Pension contributions  (530)  (569)
    Pension (income) expense  (75)  (400)
    Foreign exchange (gain) loss  376   (584)
    Noncash lease expense  1,590   1,423 
    Noncash interest expense  28   19 
    Change in manufacturing warranty obligation estimate  (626)  — 
    Deferred and other noncash income tax expense  (304)  58 
    Changes in operating assets and liabilities:      
    Accounts receivable  1,853   (514)
    Inventories  (3,259)  518 
    Due from related parties  1,018   (969)
    Due to related parties  3,337   2,471 
    Other assets  (229)  (1,805)
    Operating lease liabilities  (1,782)  (1,448)
    Accounts payable  2,920   38 
    Employee compensation  (551)  (151)
    Other liabilities  970   (96)
    Deferred revenue  (90)  4,059 
    Manufacturing warranty obligation  163   160 
    Advance payments from customers  4,338   2,083 
    Accrued expense and other current liabilities  1,071   3,126 
    Net cash provided by operating activities  5,192   5,501 
    Cash flows from investing activities:      
    Purchases of property and equipment  (202)  (145)
    Net cash used in investing activities  (202)  (145)
    Cash flows from financing activities:      
    Proceeds from reverse recapitalization  899   — 
    Payments on related party notes payable  (5,844)  (4,053)
    Net cash used in financing activities  (4,945)  (4,053)
    Effect of currency translation on cash and cash equivalents  5   (61)
    Net increase in cash, and cash equivalents, and restricted cash  50   1,242 
    Cash, and cash equivalents, and restricted cash - beginning of year  3,175   1,933 
    Cash, and cash equivalents, and restricted cash - end of year $3,225  $3,175 
    Cash and cash equivalents - end of year $3,225  $3,175 
    Restricted cash - end of year  —   — 
    Total cash, and cash equivalents, and restricted cash - end of year $3,225  $3,175 
    Supplemental disclosure of cash flow information:      
    Interest paid $665  $258 
    Income tax paid $—  $210 
    Supplemental disclosure of non-cash investing and financing activity:      
    Accrued liability related to asset acquisition $—  $533 
    Accounts payable settled through escrow account upon reverse recapitalization $1,439  $— 


    Primary Logo

    Get the next $DHAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DIH Announces Fiscal 2025 Fourth Quarter and Fiscal Year End Financial Results

    NORWELL, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Recent Highlights Revenue of $62.9 million for the fiscal year ended March 31, 2025, representing a decrease of 2.5% over the prior year Device revenue of $49.7

    10/20/25 5:05:09 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holding US, Inc. Announces Reverse Stock Split of its Series A Common Stock

    NORWELL, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) today announced that it will implement a reverse stock split of its Class A Common Stock, par value $0.0001 per share (the "Common Stock"), at a ratio of 1-for-25 (the "Reverse Stock Split"). The Reverse Stock Split was approved by the Company's stockholders at the Company's Special Meeting of Stockholders held on September 25, 2025, with the final ratio subsequently determined by the Company's Board of Directors on September 26, 2025. The Reverse Stock Split will take effect at market open on October 20, 2025, and the Common Stock will trade on a post-split basis on the Nasdaq Sto

    10/16/25 8:00:00 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holding US, Inc. Clarifies Previous Disclosure Regarding Additional Nasdaq Staff Determination Letter

    NORWELL, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- On September 18, 2025, DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) issued a press release disclosing that it had received a notice on September 12, 2025, from the Listing Qualifications Staff ("Staff") of the Nasdaq Stock Market LLC ("Nasdaq") that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the "Bid Price Rule"), so this matter was an additional basis for delisting. The Company is clarifying that since it was not current in filing its Form 10-Q for the period ended June 30, 2025, and Form 10-K for the fiscal year ended March 31, 2025 under Nasdaq Listing Rule 5250(c)(1) (the "Reports Rule"),

    10/1/25 8:11:40 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Mooney Barrett claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    9/8/25 5:15:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Burell Scott R claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    8/11/25 4:05:17 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Streppa Dennis claimed ownership of 78,022 shares (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    7/25/25 4:30:13 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    SEC Filings

    View All

    DIH Holdings US Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    11/26/25 9:32:54 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Unregistered Sales of Equity Securities

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    11/6/25 6:03:40 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Holdings US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - DIH HOLDING US, INC. (0001883788) (Filer)

    10/21/25 4:45:55 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    View All

    DIH Announces Fiscal 2025 Fourth Quarter and Fiscal Year End Financial Results

    NORWELL, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Recent Highlights Revenue of $62.9 million for the fiscal year ended March 31, 2025, representing a decrease of 2.5% over the prior year Device revenue of $49.7

    10/20/25 5:05:09 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Barrett Mooney, Ph.D to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Barrett Mooney, Ph.D. to its Board of Directors. Barrett Mooney, Ph.D., has an extensive track record of growing complex and manufacturing related businesses. He currently provides strategic advisory services to growing high-technology private and public compan

    9/8/25 4:46:27 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 6:07:49 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 12:46:18 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by DIH Holdings US Inc.

    SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

    2/20/24 5:18:47 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care